Markowski Investments’s Organon & Co OGN Stock Holding History

Markowski Investments’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$541	Buy	40 +1	+3%	+$14	﹤0.01%	659
2026 Q2	$534	Buy	+39	New	+$466	﹤0.01%	591

Other funds holding OGN

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Soros Fund Management New York $8.51B AUM 25.51% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Markowski Investments's OGN Position: Q3 2026 in Review

Markowski Investments increased its Organon & Co (OGN) stake by 2.6% in Q3 2026, buying an estimated $14 and bringing the position to 40 shares worth $541. The position accounts for ﹤0.01% of the portfolio, ranked #659.

Markowski Investments first reported a position in OGN in Q2 2026 and has held it in 2 quarters since. 494 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

Markowski Investments held 40 shares of Organon & Co worth $541 as of Q3 2026.
Markowski Investments bought 1 Organon & Co share in Q3 2026, an estimated $14.
Organon & Co made up ﹤0.01% of Markowski Investments's portfolio in Q3 2026, its #659 holding.
Markowski Investments first reported a position in Organon & Co in Q2 2026 and has held it in 2 quarters since.
494 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Markowski Investments's 13F filing for Q3 2026, filed 30 Oct 2026.